125 related articles for article (PubMed ID: 37625825)
1.
Smith-Norowitz TA; Silverberg JI; Abdelmajid H; Joks R; Kohlhoff S
Ann Clin Lab Sci; 2023 Jul; 53(4):673-675. PubMed ID: 37625825
[No Abstract] [Full Text] [Related]
2. Allergic rhinoconjunctivitis doubles the risk for incident asthma--results from a population study in Helsinki, Finland.
Pallasaho P; Juusela M; Lindqvist A; Sovijärvi A; Lundbäck B; Rönmark E
Respir Med; 2011 Oct; 105(10):1449-56. PubMed ID: 21600752
[TBL] [Abstract][Full Text] [Related]
3. Body mass index, asthma and allergic rhinoconjunctivitis in Swedish conscripts-a national cohort study over three decades.
Bråbäck L; Hjern A; Rasmussen F
Respir Med; 2005 Aug; 99(8):1010-4. PubMed ID: 15950142
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
Chelladurai Y; Suarez-Cuervo C; Erekosima N; Kim JM; Ramanathan M; Segal JB; Lin SY
J Allergy Clin Immunol Pract; 2013; 1(4):361-9. PubMed ID: 24565541
[TBL] [Abstract][Full Text] [Related]
5. The validity of register data to identify children with atopic dermatitis, asthma or allergic rhinoconjunctivitis.
Stensballe LG; Klansø L; Jensen A; Haerskjold A; Thomsen SF; Simonsen J
Pediatr Allergy Immunol; 2017 Sep; 28(6):535-542. PubMed ID: 28632331
[TBL] [Abstract][Full Text] [Related]
6. Association of atopy, asthma, allergic rhinoconjunctivitis, atopic dermatitis and intestinal helminth infections in Cuban children.
Wördemann M; Diaz RJ; Heredia LM; Collado Madurga AM; Ruiz Espinosa A; Prado RC; Millan IA; Escobedo A; Rojas Rivero L; Gryseels B; Gorbea MB; Polman K
Trop Med Int Health; 2008 Feb; 13(2):180-6. PubMed ID: 18304263
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review.
Erekosima N; Suarez-Cuervo C; Ramanathan M; Kim JM; Chelladurai Y; Segal JB; Lin SY
Laryngoscope; 2014 Mar; 124(3):616-27. PubMed ID: 23832632
[TBL] [Abstract][Full Text] [Related]
8. Disparate geographic prevalences of asthma, allergic rhinoconjunctivitis and atopic eczema among adolescents in five Canadian cities.
Wang HY; Pizzichini MM; Becker AB; Duncan JM; Ferguson AC; Greene JM; Rennie DC; Senthilselvan A; Taylor BW; Sears MR
Pediatr Allergy Immunol; 2010 Aug; 21(5):867-77. PubMed ID: 20492543
[TBL] [Abstract][Full Text] [Related]
9. Incidence rates of atopic dermatitis, asthma, and allergic rhinoconjunctivitis in Danish and Swedish children.
Henriksen L; Simonsen J; Haerskjold A; Linder M; Kieler H; Thomsen SF; Stensballe LG
J Allergy Clin Immunol; 2015 Aug; 136(2):360-6.e2. PubMed ID: 25828267
[TBL] [Abstract][Full Text] [Related]
10. CD1d expressed in mast cell surface enhances IgE production in B cells by up-regulating CD40L expression and mediator release in allergic asthma in mice.
Hong GU; Kim NG; Kim TJ; Ro JY
Cell Signal; 2014 May; 26(5):1105-17. PubMed ID: 24509414
[TBL] [Abstract][Full Text] [Related]
11. Activation of TLR Signaling in Sensitization-Recruited Inflammatory Monocytes Attenuates OVA-Induced Allergic Asthma.
Huang C; Wang J; Zheng X; Chen Y; Wei H; Sun R; Tian Z
Front Immunol; 2018; 9():2591. PubMed ID: 30510553
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of positive skin prick tests, allergic asthma, and rhinoconjunctivitis in teenagers in northern Sweden.
Norrman E; Rosenhall L; Nyström L; Jönsson E; Stjernberg N
Allergy; 1994 Dec; 49(10):808-15. PubMed ID: 7709989
[TBL] [Abstract][Full Text] [Related]
13. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.
Dahl R; Stender A; Rak S
Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194
[TBL] [Abstract][Full Text] [Related]
14. The influence of early-life animal exposure on the risk of childhood atopic dermatitis, asthma and allergic rhinoconjunctivitis: findings from the Danish National Birth Cohort.
Pinot De Moira A; Pearce N; Pedersen M; Nybo Andersen AM
Int J Epidemiol; 2023 Aug; 52(4):1231-1242. PubMed ID: 37018630
[TBL] [Abstract][Full Text] [Related]
15. The increase of asthma prevalence has levelled off and symptoms decreased in adults during 20 years from 1996 to 2016 in Helsinki, Finland.
Hisinger-Mölkänen H; Pallasaho P; Haahtela T; Lindqvist A; Sovijärvi A; Piirilä P
Respir Med; 2019 Aug; 155():121-126. PubMed ID: 31344661
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of symptoms of asthma, allergic rhinitis, conjunctivitis and atopic eczema: ISAAC (International Study of Asthma and Allergies in Childhood) in a population of schoolchildren in Zagreb].
Stipić-Marković A; Pevec B; Pevec MR; Custović A
Acta Med Croatica; 2003; 57(4):281-5. PubMed ID: 14639862
[TBL] [Abstract][Full Text] [Related]
17. Sibling number and prevalence of allergic disorders in pregnant Japanese women: baseline data from the Kyushu Okinawa Maternal and Child Health Study.
Miyake Y; Tanaka K; Arakawa M
BMC Public Health; 2011 Jul; 11():561. PubMed ID: 21752304
[TBL] [Abstract][Full Text] [Related]
18. Smoking and prevalence of allergic disorders in Japanese pregnant women: baseline data from the Kyushu Okinawa Maternal and Child Health Study.
Tanaka K; Miyake Y; Arakawa M
Environ Health; 2012 Mar; 11():15. PubMed ID: 22413964
[TBL] [Abstract][Full Text] [Related]
19. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
20. Off-label Use of Oral Immunotherapy for Rhinoconjunctivitis and Asthma due to Grass Pollen: A Safe and Effective Alternative in Patients over 65 Years Old: A Series of Case Reports.
González-Bravo L; García JL; Privitera M; Rosado A
Curr Drug Saf; 2023; 18(4):599-602. PubMed ID: 36221873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
